Drug intelligence / Profile preview

tyrosinase-related protein-1

Development stage
Phase 2
Lead developer
Eli Lilly
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular, Subcutaneous, Intradermal, Intratumoral
01

Overview

Tyrosinase-related protein 1 (TYRP1) is a melanosomal enzyme and member of the tyrosinase family, primarily expressed in melanocytes. It plays a key role in the biosynthesis of melanin, the pigment responsible for skin, hair, and eye color. While its precise catalytic function in human melanocytes is less clear than that of tyrosinase itself, TYRP1 is involved in stabilizing tyrosinase and modulating its activity as well as maintaining melanosome structure. Structurally, it contains two zinc ions at its active site (unlike copper ions found in classic tyrosinases), which explains why it does not exhibit typical redox activity associated with tyrosinases[2][3]. Mutations or alterations in TYRP1 are linked to pigmentation disorders such as oculocutaneous albinism type 3[1]. In oncology research, recombinant forms or peptides derived from TYRP1 have been explored as vaccine antigens or immunotherapy targets for melanoma due to their expression on melanocyte-derived tumors[7][9].

Other names
tyrosinase-related protein 1TYRP1_HUMAN
02

Targets

TYRP1 (Tyrosinase-related protein 1)

Beyond the preview

Go deeper on tyrosinase-related protein-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tyrosinase-related protein-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call